 |
||
|
Autologous cell immunotherapeutics
R&D in anti-inflammatory immunotherapy. Innovative autologous cell therapies against chronic debilitating illness such as Crohn’s disease, multiple sclerosis, psoriasis, asthma or rheumatoid arthritis. First product entered into clinical trials in 1Q 2008. |